{"DataElement":{"publicId":"2938522","version":"1","preferredName":"Patient Bevacizumab Eligibility Status","preferredDefinition":"the status of a patient to participate in the clinical study using Bevacizumab (a monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor).","longName":"2552382v1.0:2938512v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2552382","version":"1","preferredName":"Patient Bevacizumab Eligibility","preferredDefinition":"information relating to whether eligibility criteria for Bevacizumab (a monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor) have been met for the patient to participate in the clinical study.","longName":"PT_BEVACIZ_ELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2552378","version":"1","preferredName":"Bevacizumab Eligibility Determination","preferredDefinition":"A monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C2039:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bevacizumab","conceptCode":"C2039","definition":"A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine.  Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"246B4458-6721-142A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-12-12","modifiedBy":"ONEDATA","dateModified":"2006-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"246B4458-6732-142A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-12-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2938512","version":"1","preferredName":"Bevacizumab Eligibility Status","preferredDefinition":"the condition or state at a particular time related to eligibility for treatment with bevacizumab.","longName":"2938512v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Bevacizumab eligible and will elect not to receive bevacizumab","valueDescription":"Bevacizumab eligible and will elect not to receive bevacizumab","ValueMeaning":{"publicId":"2938513","version":"1","preferredName":"Bevacizumab eligible and will elect not to receive bevacizumab","longName":"2938513","preferredDefinition":"Bevacizumab eligible and will elect not to receive bevacizumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72AE2494-ABAD-A35A-E040-BB89AD43137B","latestVersionIndicator":"Yes","beginDate":"2009-09-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"72AE2494-ABC6-A35A-E040-BB89AD43137B","beginDate":"2009-09-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-03","modifiedBy":"ONEDATA","dateModified":"2009-09-03","deletedIndicator":"No"},{"value":"Bevacizumab eligible and will receive bevacizumab","valueDescription":"Bevacizumab eligible and will receive bevacizumab","ValueMeaning":{"publicId":"2938514","version":"1","preferredName":"Bevacizumab eligible and will receive bevacizumab","longName":"2938514","preferredDefinition":"Bevacizumab eligible and will receive bevacizumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72AE2494-ABD0-A35A-E040-BB89AD43137B","latestVersionIndicator":"Yes","beginDate":"2009-09-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"72AE2494-ABE9-A35A-E040-BB89AD43137B","beginDate":"2009-09-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-03","modifiedBy":"ONEDATA","dateModified":"2009-09-03","deletedIndicator":"No"},{"value":"Bevacizumab ineligible","valueDescription":"Bevacizumab ineligible","ValueMeaning":{"publicId":"2938515","version":"1","preferredName":"Bevacizumab ineligible","longName":"2938515","preferredDefinition":"Bevacizumab ineligible","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72AE2494-ABF3-A35A-E040-BB89AD43137B","latestVersionIndicator":"Yes","beginDate":"2009-09-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"72AE2494-AC0C-A35A-E040-BB89AD43137B","beginDate":"2009-09-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-03","modifiedBy":"ONEDATA","dateModified":"2009-09-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72AE2494-AB98-A35A-E040-BB89AD43137B","latestVersionIndicator":"Yes","beginDate":"2009-09-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-03","modifiedBy":"CAMPBELB","dateModified":"2009-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Bevacizumab eligibility","type":"Preferred Question Text","description":"Bevacizumab eligibility","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"72AE2494-AC16-A35A-E040-BB89AD43137B","latestVersionIndicator":"Yes","beginDate":"2009-09-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-03","modifiedBy":"CAMPBELB","dateModified":"2009-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}